Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Artefenomel Granules with Piperaquine in Healthy Subjects
NCT02387580Phase 1Completed
- Sponsor
- Medicines for Malaria Venture
- Start
- Apr 2015
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of artefenomel in malaria (6 arms), sponsored by Medicines for Malaria Venture. Primary endpoints: Maximum Plasma Concentration (Cmax) of OZ439, Area Under the Curve (AUC0-168h) of OZ439 and 2 more. Started Apr 2015; status: completed.
02
Drugs
artefenomel
03
Conditions
malaria
Beyond the preview
Go deeper on NCT02387580.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02387580.